Fei Hu
Impact in
-
- Supercapacitor Materials and Fabrication
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- RNA modifications and cancer 2
- Oncology 8
- Co-authors
- Congcong Liu (1 shared paper)Xiaowei Yang (1 shared paper)Xiaojun Yan (1 shared paper)Guohua Gao (1 shared paper)Guangming Wu (1 shared paper)Xianling Guo (10 shared papers)Qing Xu (13 shared papers)Lixin Wei (5 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Cancer Letters (4 papers)Oncology Reports (2 papers)Biomarkers (1 paper)Journal of Cellular Physiology (1 paper)
- Partner nations
- ChinaNorwayUnited States
In The Last Decade
Fei Hu
27 papers receiving 820 citations
Peers
Comparison fields: 5 of 94
- Electronic, Optical and Magnetic Materials 222
- Cancer Research 146
- Physiology 40
- Epidemiology 261
- Geriatrics and Gerontology 28
Countries citing papers authored by Fei Hu
This map shows the geographic impact of Fei Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Hu more than expected).
Fields of papers citing papers by Fei Hu
This network shows the impact of papers produced by Fei Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Hu. The network helps show where Fei Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 252 | |
| 2 | 2012 | 158 | |
| 3 | 2009 | 69 | |
| 4 | 2017 | 55 | |
| 5 | 2016 | 47 | |
| 6 | 2014 | 34 | |
| 7 | 2014 | 32 | |
| 8 | 2018 | 31 | |
| 9 | 2019 | 28 | |
| 10 | 2013 | 21 | |
| 11 | 2015 | 19 | |
| 12 | 2017 | 14 | |
| 13 | Prognostic role of vascular endothelial growth factor in prostate cancer: a systematic review and meta-analysis. | 2015 | 14 |
| 14 | 2021 | 12 | |
| 15 | 2017 | 12 | |
| 16 | 2010 | 8 | |
| 17 | 2018 | 4 | |
| 18 | 2015 | 3 | |
| 19 | [Total hip replacement with collum femoris preserving for the treatment of advanced stage of femoral head necrosis of young patients: a report of results of more than five years follow-up]. | 2010 | 3 |
| 20 | 2020 | 3 |
About Fei Hu
Fei Hu is a scholar working on Molecular Biology, Oncology, Epidemiology, Cell Biology and Surgery, having authored 29 papers that have together received 828 indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (8 papers), Endoplasmic Reticulum Stress and Disease (4 papers), Electric and Hybrid Vehicle Technologies (3 papers), Vehicle Dynamics and Control Systems (2 papers), Sirtuins and Resveratrol in Medicine (2 papers), RNA modifications and cancer (2 papers), Real-time simulation and control systems (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Electronic, Optical and Magnetic Materials (222 citations), Cancer Research (146 citations), Physiology (40 citations), Epidemiology (261 citations) and Geriatrics and Gerontology (28 citations). Fei Hu has collaborated with scholars based in China, Norway and United States. Frequent co-authors include Congcong Liu, Xiaowei Yang, Xiaojun Yan, Guohua Gao, Guangming Wu, Xianling Guo, Qing Xu, Lixin Wei, Shanshan Zhang and Mengchao Wu. Their work appears in journals such as Journal of Clinical Oncology, Cancer Letters, Oncology Reports, Biomarkers and Journal of Cellular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.